Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:26:13.538Z.
Calculation as of: 2026-10-06T14:26:13.538Z.
Quote observation: 2026-10-06T14:25:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b2d28e84da0c930e75004ae600b803967d1975629f72cad3bf33ad83c9831f21
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Eikon Therapeutics, Inc. Common Stock
Market Cap
$411.99M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$412.27M
Free Cash Flow Yield
N/A
TTM Avg
0.27%
3Y Avg
3.53%
5Y Avg
4.14%
Market Cap
$407.09M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$406.54M
Free Cash Flow Yield
N/A
TTM Avg
24.51%
3Y Avg
24.51%
5Y Avg
24.51%
Market Cap
$425.86M
Free Cash Flow Yield
N/A
TTM Avg
2.75%
3Y Avg
2.75%
5Y Avg
2.75%
Market Cap
$432.69M
Free Cash Flow Yield
N/A
TTM Avg
4.98%
3Y Avg
4.98%
5Y Avg
4.98%
Market Cap
$437.27M
Free Cash Flow Yield
N/A
TTM Avg
28.70%
3Y Avg
28.70%
5Y Avg
28.70%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. Common Stock (EIKN) | $411.99M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $412.27M | N/A | 0.27% | 3.53% | 4.14% |
| Carlsmed, Inc. (CARL)vs › | $408.32M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $407.09M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $406.54M | N/A | 24.51% | 24.51% | 24.51% |
| Neurogene Inc. (NGNE)vs › | $402.01M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $425.86M | N/A | 2.75% | 2.75% | 2.75% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $432.69M | N/A | 4.98% | 4.98% | 4.98% |
| Assembly Biosciences, Inc. (ASMB)vs › | $437.27M | N/A | 28.70% | 28.70% | 28.70% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $384.04M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
